SCHEMBL98304

SCHEMBL98304

C[CH]c1ccccc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 5/20 0.57
CA1 P00915 3/20 0.57
CA2 P00918 3/20 0.57
CA7 P43166 2/20 0.57
CA9 Q16790 2/20 0.57
TRPA1 O75762 1/20 0.57
CA12 O43570 1/20 0.57
CA4 P22748 1/20 0.57
CA14 Q9ULX7 1/20 0.57
TFEB P19484 1/20 0.53
CYP1A1 P04798 3/20 0.52
CYP1A2 P05177 3/20 0.52
CYP1B1 Q16678 3/20 0.52
KDM4E B2RXH2 3/20 0.52
CYP19A1 P11511 1/20 0.50
GRIN2D O15399 2/20 0.48
GRIN3B O60391 2/20 0.48
GRIN1 Q05586 2/20 0.48
GRIN2A Q12879 2/20 0.48
GRIN2B Q13224 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27343543 0.98 NFE2L2 (0.55) NFE2L2CA1CA2CA7CA9
SCHEMBL1603719 0.82 NFE2L2 (0.79) NFE2L2CA1CA2CA7CA9
SCHEMBL240090 0.82 CA1 (0.60) NFE2L2CA1CA2CA7CA9
SCHEMBL4019329 0.82 NFE2L2 (0.79) NFE2L2CA1CA2CA7CA9
SCHEMBL7915752 0.82 NFE2L2 (0.79) NFE2L2CA1CA2CA7CA9
SCHEMBL29580852 0.81 NFE2L2 (0.64) NFE2L2CA1CA2CA7CA9
SCHEMBL4461398 0.81 NFE2L2 (0.64) NFE2L2CA1CA2CA7CA9
SCHEMBL1883472 0.81 NFE2L2 (0.64) NFE2L2CA1CA2CA7CA9
SCHEMBL1883475 0.81 NFE2L2 (0.64) NFE2L2CA1CA2CA7CA9
SCHEMBL7051005 0.80 NFE2L2 (0.61) NFE2L2CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 849 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3688124-B1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-25 EP claimed
WO-2023177250-A1 NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 숙명여자대학교산학협력단 2023-09-21 WO claimed
CN-116143638-A Method for preparing nitrogen-containing aromatic compound by catalyzing lignin through Fe-terpyridine 中国科学院大连化学物理研究所 2023-05-23 CN claimed
CN-116143631-A Pd/SnO 2 Method for preparing nitrogen-containing aromatic compound by catalyzing lignin 中国科学院大连化学物理研究所 2023-05-23 CN claimed
EP-3688124-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME ExxonMobil Chemical Patents Inc. (US) 2020-08-05 EP claimed
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-07-14 US claimed
CN-111386331-A Ester compound, lubricating oil composition containing same, and method for producing same 埃克森美孚化学专利公司 2020-07-07 CN claimed
WO-2019067061-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-04-04 WO claimed
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US claimed
EP-1915149-B1 NOVEL TRIAZOLE DERIVATIVES AS GHRELIN ANALOGUE LIGANDS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS AETERNA ZENTARIS GMBH (DE) 2018-10-10 EP claimed
US-20040019049-A1 Substituted quinazolinone compounds CHIRON CORPORATION 2004-01-29 US claimed
WO-2003099818-A1 SUBSTITUTED QUINAZOLINONE COMPOUNDS CHIRON CORPORATION (US) 2003-12-04 WO claimed
US-20030195187-A1 Guanidino compounds CHIRON CORPORATION 2003-10-16 US claimed
WO-2003066597-A2 GUANIDINO COMPOUNDS CHIRON CORPORATION (US) 2003-08-14 WO claimed
EP-0758320-A1 TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS Allelix Biopharmaceuticals Inc. (CA) 1997-02-19 EP claimed
WO-1995030655-A1 TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1995-11-16 WO claimed
EP-0093010-B1 ALPHA-HYDROXYETHYLPHOSPHINATES, AND THEIR PRODUCTION AND USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-06-11 EP claimed
US-4556514-A INTERMEDIATES FOR PRODUCTION OF CARBAPENEM OR PENEM DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-12-03 US claimed
EP-0106652-A1 Beta-lactam compounds and production thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1984-04-25 EP claimed
US-3971804-A ACARICIDES, FUNGICIDES, INSECTICIDES BAYER AKTIENGESELLSCHAFT (DT) 1976-07-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195187-A1 Guanidino compounds MC4R, MC2R, GPR4 NFE2L2 4220/4885CA1 4846/4885CA2 4038/4885
US-20040019049-A1 Substituted quinazolinone compounds MC4R, MC2R, MC3R NFE2L2 4233/4885CA1 4540/4885CA2 3249/4885
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same ELOVL1, NOTUM, ELOVL5 NFE2L2 2099/4885CA1 3188/4885CA2 4780/4885
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same ELOVL1, NOTUM, ELOVL5 NFE2L2 2099/4885CA1 3188/4885CA2 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.